JP6947531B2 - 濃度予測方法、濃度予測プログラム、および濃度予測装置 - Google Patents
濃度予測方法、濃度予測プログラム、および濃度予測装置 Download PDFInfo
- Publication number
- JP6947531B2 JP6947531B2 JP2017090491A JP2017090491A JP6947531B2 JP 6947531 B2 JP6947531 B2 JP 6947531B2 JP 2017090491 A JP2017090491 A JP 2017090491A JP 2017090491 A JP2017090491 A JP 2017090491A JP 6947531 B2 JP6947531 B2 JP 6947531B2
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- spectrum
- analytical substance
- concentration prediction
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 42
- 238000001228 spectrum Methods 0.000 claims description 116
- 239000000126 substance Substances 0.000 claims description 89
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 67
- 239000008103 glucose Substances 0.000 claims description 67
- 238000001727 in vivo Methods 0.000 claims description 20
- 238000005284 basis set Methods 0.000 claims description 18
- 230000008859 change Effects 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 238000000338 in vitro Methods 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 5
- 238000012885 constant function Methods 0.000 claims description 4
- 238000012886 linear function Methods 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 3
- 238000000862 absorption spectrum Methods 0.000 claims description 2
- 239000012491 analyte Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 24
- 238000004458 analytical method Methods 0.000 description 11
- 230000005540 biological transmission Effects 0.000 description 9
- 235000003642 hunger Nutrition 0.000 description 9
- 238000012937 correction Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 230000003595 spectral effect Effects 0.000 description 7
- 238000004891 communication Methods 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 238000000513 principal component analysis Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000001678 irradiating effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000004566 IR spectroscopy Methods 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/3103—Atomic absorption analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
- A61B5/1405—Devices for taking blood samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
- A61B5/7267—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems involving training the classification device
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/42—Absorption spectrometry; Double beam spectrometry; Flicker spectrometry; Reflection spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/44—Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/4833—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N2021/0181—Memory or computer-assisted visual determination
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/59—Transmissivity
- G01N21/5907—Densitometers
- G01N2021/5915—Processing scan data in densitometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/129—Using chemometrical methods
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Artificial Intelligence (AREA)
- Emergency Medicine (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Mathematical Physics (AREA)
- Fuzzy Systems (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Evolutionary Computation (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Description
前記体内スペクトルを構成する少なくとも一つの主成分を含む基底セットを生成する段階と、前記基底セットを生成する段階で生成された基底セット、前記体内固有スペクトルを推定する過程で得られた追加の基底セット、および前記推定された体内固有スペクトルを基に、最小二乗法を行うことによって前記分析物質の体内濃度を予測する段階と、を有する。
110…学習部、
120…固有スペクトル推定部、
130…濃度予測部、
140…光送受信部、
150…通信部、
910…プロセッサー、
920…メモリ、
930…送受信部。
Claims (10)
- 分析物質の体内濃度を予測する方法であって、
前記分析物質に対する体外固有スペクトル、定数関数項、および線形関数項の線形結合を使用して前記体外固有スペクトルを補正し、補正された体外固有スペクトルに基づいて、前記分析物質に対する体内固有スペクトルを推定する段階であって、ここで、前記体外固有スペクトルは前記分析物質が溶けている水溶液から獲得される、段階と、
前記推定された体内固有スペクトルと、体内で前記分析物質の濃度が実質的に変わらない区間の間に獲得された体内スペクトルを基に濃度予測アルゴリズムを利用して前記分析物質の体内濃度を予測する段階と、
を有し、
前記予測する段階は、
前記体内スペクトルを構成する少なくとも一つの主成分を含む基底セットを生成する段階と、
前記基底セットを生成する段階で生成された基底セット、前記体内固有スペクトルを推定する過程で得られた追加の基底セット、および前記推定された体内固有スペクトルを基に、前記濃度予測アルゴリズムを行うことによって前記分析物質の体内濃度を予測する段階と、
を有し、
前記追加の基底セットは、前記定数関数項および前記線形関数項を有する、濃度予測方法。 - 前記予測する段階は、
前記体内スペクトルを構成する少なくとも一つの主成分を含む基底セットを生成する段階と、
前記基底セットを生成する段階で生成された基底セット、前記体内固有スペクトルを推定する過程で得られた追加の基底セット、および前記推定された体内固有スペクトルを基に、最小二乗法を行うことによって前記分析物質の体内濃度を予測する段階と、
を有する、請求項1に記載の濃度予測方法。 - 前記分析物質は、人体、動物、哺乳類、非哺乳類または微生物のうちの一つに含まれている分析物質である、請求項1または2に記載の濃度予測方法。
- 前記分析物質は、ブドウ糖、尿素、乳酸、トリグリセリド、蛋白質、コレステロールまたはエタノールのうちの少なくとも一つである、請求項1〜3のいずれか一つに記載の濃度予測方法。
- 前記分析物質は、ブドウ糖であり、前記分析物質の濃度が実質的に変わらない区間は、空腹区間である、請求項1〜4のいずれか一つに記載の濃度予測方法。
- 前記体内スペクトルは、赤外線の吸収スペクトルまたは反射スペクトルのうちの一つである、請求項1〜5のいずれか一つに記載の濃度予測方法。
- 前記体内スペクトルは、単一波長電磁波の散乱スペクトルである、請求項1〜6のいずれか一つに記載の濃度予測方法。
- 前記濃度予測アルゴリズムは、純分析物質信号アルゴリズムである、請求項1〜7のいずれか一つに記載の濃度予測方法。
- 分析物質の体内濃度を予測する濃度予測プログラムであって、
請求項1〜8のいずれか一つに記載の濃度予測方法をコンピューターのプロセッサーに実行させる濃度予測プログラム。 - 分析物質の体内濃度を予測する装置であって、
プロセッサーと、
前記プロセッサーに接続されたメモリと、
前記プロセッサーに接続された送受信部と
を含み、
前記プロセッサーは、前記メモリに記憶された請求項9に記載の濃度予測プログラムを実行して前記分析物質の体内濃度を予測する、濃度予測装置。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2016-0056569 | 2016-05-09 | ||
KR1020160056569A KR102497849B1 (ko) | 2016-05-09 | 2016-05-09 | 분석물질 농도 예측 방법 및 장치 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017202309A JP2017202309A (ja) | 2017-11-16 |
JP6947531B2 true JP6947531B2 (ja) | 2021-10-13 |
Family
ID=58638718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017090491A Active JP6947531B2 (ja) | 2016-05-09 | 2017-04-28 | 濃度予測方法、濃度予測プログラム、および濃度予測装置 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10966689B2 (ja) |
EP (1) | EP3244193B1 (ja) |
JP (1) | JP6947531B2 (ja) |
KR (1) | KR102497849B1 (ja) |
CN (1) | CN107440684B (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102023913B1 (ko) * | 2017-12-14 | 2019-09-23 | 광주과학기술원 | 레이저 유도 붕괴 분광법을 이용한 성분 표시 장치 |
US11504070B2 (en) * | 2018-02-23 | 2022-11-22 | Samsung Electronics Co., Ltd. | Apparatus and method for estimation concentration of blood compound |
KR102627146B1 (ko) * | 2018-07-20 | 2024-01-18 | 삼성전자주식회사 | 스펙트럼 처리 장치 및 방법 |
US11627895B2 (en) * | 2018-08-10 | 2023-04-18 | Samsung Electronics Co., Ltd. | Apparatus and method for estimating analyte concentration, and apparatus and method for generating analyte concentration estimation model |
KR102574088B1 (ko) * | 2018-08-10 | 2023-09-04 | 삼성전자주식회사 | 분석 물질의 농도 추정 장치 및 방법과, 농도 추정 모델 생성 장치 및 방법 |
KR102638310B1 (ko) * | 2018-10-04 | 2024-02-19 | 삼성전자주식회사 | 분석 물질의 농도 추정 장치 및 방법 |
CN109100324A (zh) * | 2018-10-08 | 2018-12-28 | 厦门卓越生物质能源有限公司 | 生物柴油酯交换生产过程中中性油的近红外光谱测定方法 |
KR102671886B1 (ko) * | 2018-10-23 | 2024-05-31 | 삼성전자주식회사 | 분석 물질의 농도 추정 장치 및 방법 |
KR20200058948A (ko) * | 2018-11-20 | 2020-05-28 | 삼성전자주식회사 | 스펙트럼 측정 장치, 스펙트럼의 광원 온도 변화 보정 방법, 농도 추정 장치 및 방법 |
WO2020129895A1 (ja) * | 2018-12-20 | 2020-06-25 | キヤノン株式会社 | 情報処理装置、情報処理装置の制御方法、及びプログラム |
KR20200097144A (ko) | 2019-02-07 | 2020-08-18 | 삼성전자주식회사 | 생체정보 추정 장치 및 방법 |
KR20200100997A (ko) | 2019-02-19 | 2020-08-27 | 삼성전자주식회사 | 분석 물질의 농도 추정 장치 및 방법 |
KR20200133525A (ko) * | 2019-05-20 | 2020-11-30 | 삼성전자주식회사 | 생체 정보 추정 모델의 유효성 판단 장치 및 방법 |
KR20200137103A (ko) * | 2019-05-29 | 2020-12-09 | 삼성전자주식회사 | 생체 정보 추정 모델 갱신 장치 및 방법 |
KR102410041B1 (ko) * | 2020-02-17 | 2022-06-16 | 한양대학교 산학협력단 | 딥러닝을 이용한 광물 조성 예측 방법 및 그 장치 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5511033B2 (ja) | 1972-03-09 | 1980-03-21 | ||
US6240306B1 (en) * | 1995-08-09 | 2001-05-29 | Rio Grande Medical Technologies, Inc. | Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration |
US6040578A (en) * | 1996-02-02 | 2000-03-21 | Instrumentation Metrics, Inc. | Method and apparatus for multi-spectral analysis of organic blood analytes in noninvasive infrared spectroscopy |
US7039446B2 (en) * | 2001-01-26 | 2006-05-02 | Sensys Medical, Inc. | Indirect measurement of tissue analytes through tissue properties |
US20060009633A9 (en) * | 1997-11-13 | 2006-01-12 | Genset, S.A. | Complementary DNAs encoding proteins with signal peptides |
US8974386B2 (en) * | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US20080184017A1 (en) | 1999-04-09 | 2008-07-31 | Dave Stuttard | Parallel data processing apparatus |
EP1181648A1 (en) | 1999-04-09 | 2002-02-27 | Clearspeed Technology Limited | Parallel data processing apparatus |
US7317938B2 (en) * | 1999-10-08 | 2008-01-08 | Sensys Medical, Inc. | Method of adapting in-vitro models to aid in noninvasive glucose determination |
US7133710B2 (en) | 2002-03-08 | 2006-11-07 | Sensys Medical, Inc. | Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy |
CA2441078A1 (en) | 2001-01-26 | 2002-08-22 | Sensys Medical, Inc. | Noninvasive measurement of glucose through the optical properties of tissue |
KR100493154B1 (ko) * | 2002-03-20 | 2005-06-03 | 삼성전자주식회사 | 광음향분광학을 이용한 비침습적 생체성분 측정장치 |
US7725144B2 (en) | 2002-04-04 | 2010-05-25 | Veralight, Inc. | Determination of disease state using raman spectroscopy of tissue |
US6801316B2 (en) * | 2002-07-19 | 2004-10-05 | Optix Lp | Measurement of an analyte concentration in a scattering medium |
US20090118605A1 (en) * | 2002-08-30 | 2009-05-07 | Northwestern University | Surface-enhanced raman nanobiosensor |
US7633621B2 (en) * | 2003-04-11 | 2009-12-15 | Thornton Robert L | Method for measurement of analyte concentrations and semiconductor laser-pumped, small-cavity fiber lasers for such measurements and other applications |
US20120078473A1 (en) * | 2004-05-24 | 2012-03-29 | Trent Ridder | Apparatus and Method for Controlling Operation of Vehicles or Machinery by Intoxicated or Impaired Individuals |
WO2006040841A1 (ja) | 2004-10-15 | 2006-04-20 | Nagasaki Prefectural Government | 血糖値の非侵襲測定装置 |
US7460895B2 (en) * | 2005-01-24 | 2008-12-02 | University Of Iowa Research Foundation | Method for generating a net analyte signal calibration model and uses thereof |
US20060173260A1 (en) * | 2005-01-31 | 2006-08-03 | Gmms Ltd | System, device and method for diabetes treatment and monitoring |
WO2007014173A2 (en) | 2005-07-22 | 2007-02-01 | Massachusetts Institute Of Technology | Intrinsic raman spectroscopy |
US7946985B2 (en) | 2006-12-29 | 2011-05-24 | Medtronic Minimed, Inc. | Method and system for providing sensor redundancy |
KR100883153B1 (ko) | 2007-04-20 | 2009-02-10 | 나가사끼-켄 | 혈당치의 비침습 측정 장치 |
US7783442B2 (en) | 2007-10-31 | 2010-08-24 | Medtronic Minimed, Inc. | System and methods for calibrating physiological characteristic sensors |
EP2268197A1 (en) * | 2008-03-31 | 2011-01-05 | Onablab AB | Method and device for non-invasive determination of the concentration of a substance in a body fluid |
US20110168575A1 (en) | 2010-01-08 | 2011-07-14 | Roche Diaagnostics Operations, Inc. | Sample characterization based on ac measurement methods |
KR101656746B1 (ko) | 2010-10-26 | 2016-09-12 | 엘지전자 주식회사 | 혈당농도 보정 장치 및 방법 |
US8976358B2 (en) * | 2012-03-23 | 2015-03-10 | Spectrasensors, Inc. | Collisional broadening compensation using real or near-real time validation in spectroscopic analyzers |
JP5511033B1 (ja) | 2012-12-04 | 2014-06-04 | Necシステムテクノロジー株式会社 | 血糖値予測装置、測定装置、血糖値予測方法、及びプログラム |
WO2014141034A2 (en) * | 2013-03-15 | 2014-09-18 | Richard Harry Turner | A system and methods for the in vitro detection of particles and soluble chemical entities in body fluids |
JP5675889B2 (ja) | 2013-05-08 | 2015-02-25 | メドトロニック ミニメド インコーポレイテッド | センサ値を用いてインスリンを注入するための閉ループ装置または半閉ループ装置 |
CN103876749A (zh) * | 2014-04-04 | 2014-06-25 | 王素常 | 内置光谱法快速血糖检测系统 |
CN204318763U (zh) * | 2014-11-12 | 2015-05-13 | 杭州欣安医疗科技有限公司 | 一种基于近红外检测人体生化参数的检测装置 |
CN104367327B (zh) * | 2014-11-12 | 2016-09-14 | 杭州欣安医疗科技有限公司 | 一种基于近红外检测人体生化参数的检测装置及方法 |
-
2016
- 2016-05-09 KR KR1020160056569A patent/KR102497849B1/ko active IP Right Grant
-
2017
- 2017-04-26 EP EP17168232.1A patent/EP3244193B1/en active Active
- 2017-04-28 JP JP2017090491A patent/JP6947531B2/ja active Active
- 2017-05-04 CN CN201710306695.XA patent/CN107440684B/zh active Active
- 2017-05-09 US US15/590,094 patent/US10966689B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3244193A1 (en) | 2017-11-15 |
CN107440684A (zh) | 2017-12-08 |
KR102497849B1 (ko) | 2023-02-07 |
JP2017202309A (ja) | 2017-11-16 |
CN107440684B (zh) | 2022-08-23 |
KR20170126310A (ko) | 2017-11-17 |
EP3244193B1 (en) | 2022-10-19 |
US10966689B2 (en) | 2021-04-06 |
US20170319185A1 (en) | 2017-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6947531B2 (ja) | 濃度予測方法、濃度予測プログラム、および濃度予測装置 | |
Lundsgaard-Nielsen et al. | Critical-depth Raman spectroscopy enables home-use non-invasive glucose monitoring | |
US7961312B2 (en) | Calibrated analyte concentration measurements in mixtures | |
KR102655737B1 (ko) | 생체 성분 추정 장치 및 방법 | |
JP4672147B2 (ja) | 分光学的な較正モデルを作るための方法 | |
Yu et al. | An accurate noninvasive blood glucose measurement system using portable near-infrared spectrometer and transfer learning framework | |
JP6783596B2 (ja) | 分析物質の濃度予測方法および装置 | |
JP6775660B2 (ja) | 多位置拡散スペクトルデータの処理、モデリング、予測方法および処理装置 | |
JP6441812B2 (ja) | 体液試料を分析する方法 | |
JP2004501357A (ja) | 分光学的キャリブレーションモデルを移行するための方法並びに装置 | |
Suryakala et al. | Investigation of goodness of model data fit using PLSR and PCR regression models to determine informative wavelength band in NIR region for non-invasive blood glucose prediction | |
KR102638310B1 (ko) | 분석 물질의 농도 추정 장치 및 방법 | |
Watté et al. | Robust metamodel-based inverse estimation of bulk optical properties of turbid media from spatially resolved diffuse reflectance measurements | |
KR102461185B1 (ko) | 스펙트럼 분석법을 이용한 혈중 성분 수치의 추정 장치 | |
JP6813848B2 (ja) | 成分濃度測定装置及び方法 | |
Chauchard et al. | Localization of embedded inclusions using detection of fluorescence: Feasibility study based on simulation data, LS-SVM modeling and EPO pre-processing | |
JP6521307B2 (ja) | 近赤外分光法を用いた生体特性値測定方法及び測定装置 | |
US11089981B2 (en) | Methods and systems for performing universal calibration to non-invasively determine blood glucose concentration | |
KR20200010991A (ko) | 혈당 농도를 결정하는 장치 및 방법 | |
JP2017060640A (ja) | 判定方法、判定装置 | |
Naqvi et al. | Improving accuracy of non-invasive glucose monitoring through non-local data denoising |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191111 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201215 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210315 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210512 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210810 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210907 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210916 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6947531 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |